News

Operation Nunalivut

On February 11th, two long-standing Tilray employees left Nanaimo to serve our country as part of the Canadian Armed Forces Operation Nunalivut 2017 in the Canadian arctic. According to the to the federal government, Operation Nunalivut is a sovereignty operation that has been conducted annually sin Read More

Tilray® 2:100 Product Shows Promise in Canada’s First Pediatric Study of Mixed THC/CBD Medical Cannabis Oil for Children with Drug-Resistant Epilepsy

Research conducted at The Hospital for Sick Children (SickKids) establishes promising safety and tolerability data for Tilray 2:100 oil for children with drug-resistant epilepsy (DRE) due to Dravet Syndrome

NANAIMO, BRITISH COLUMBIA – Tilray Inc., a global Read More

Tilray Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares

Tilray, Inc. (NASDAQ: TLRY), a vertically-integrated and federally-licensed cannabis cultivator, processor and distributor, today announced the closing of its initial public offering (IPO) of 10,350,000 shares of Class 2 common stock, including the full exercise by the underwriters of their optio Read More